Filter posts

WSJ: Drug Importation is “Impractical, Unsafe and Unlikely” to Lower Prices

This week, Editorial Board writers for The Wall Street Journal examined a policy proposal in …

Greenwood Shines Spotlight on Insurance Industry Rip-off

Writing for The Hill, BIO’s President and CEO Jim Greenwood shined a spotlight on a …

Former Anti-GMO Activist: To Accept GMOs Is To Accept Science

There is no doubting that genetic engineering will be a major part of the future …

ICYMI: WSJ Editors on “Biotech’s Breakthrough Year”

2017 was an amazing year for biomedical advances, with 46 novel drug approvals, a near …

ICYMI: Reducing Regulatory Hurdles Can Help Boost Innovation

Featured this week in the Wall Street Journal, columnist Greg Ip discusses how reducing regulatory hurdles …

Vaccines: The Greatest Live-Saving Health Success

Vaccines have proven to be one of the greatest public health accomplishments of the 20th …

ICYMI: How Other Countries Freeload on U.S. Drug Research -WSJ

Writing for the Wall Street Journal this week, former FDA Associate Commissioner Peter Pitts has …

Vaccine-Preventable Outbreaks on the Rise

Since the fall of 2008, the Council on Foreign Relations has been tracking outbreaks of …

WSJ: A Piece of the Immunotherapy Puzzle Solved

Just two weeks ago, the New York Times published a series of articles deeming immunotherapy …

Stop Demeaning the Healthy Dialogue Between Doctors and Drug Companies

A recent report in The Wall Street Journal entitled, “Even Cheap Meals Influence Doctors’ Drug …